• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Stock

Amazon same-day prescription delivery expanding to nearly half of U.S. in 2025

by October 9, 2024
written by October 9, 2024

Amazon plans to bring same-day prescription delivery to 20 more cities next year, the company said Wednesday, marking the latest phase of its push into health care.

As part of the expansion, which will make speedy medicine delivery available in nearly half of the U.S., Amazon said, it is embedding pharmacies in same-day delivery facilities often clustered around major metro areas. The company announced its plans during a press event at one of its warehouses near Nashville, Tennessee.

Amazon in March introduced same-day pharmacy delivery in New York and Los Angeles, after launching the service in Indianapolis, Miami, Phoenix, Seattle, and Austin, Texas. Some of the cities that will be added in 2025 include Boston, Dallas, Minneapolis, Philadelphia and San Diego.

The company has worked to accelerate medication deliveries. It’s been testing prescription delivery by drone in one Texas city. In most cases, the company said, when shoppers order same-day delivery of their medication by 4 p.m. they can receive it at home by 10 p.m.

The prescriptions are offered through Amazon Pharmacy, a section of its website and app that allows shoppers to order medication, with free delivery for Prime members. Launched in 2020, Amazon Pharmacy was born out of the company’s 2018 acquisition of online pharmacy PillPack. The company in January said it had doubled the number of customers it serves in the past year, though it didn’t provide a specific number.

It faces competition from traditional pharmacies such as CVS and Walgreens, as well as other large retailers that offer pharmacy services, such as Walmart. Amazon said Wednesday it’s capitalizing on the care gaps created by the growing number of “pharmacy deserts” in the U.S., which can limit a patient’s access to medications and pharmacist care. Chain stores such as Walgreens and CVS have shuttered hundreds of locations recently as they struggle to maintain profitability.

Amazon’s online pharmacy is a part of the company’s multiyear effort to make inroads in the health-care industry. The company acquired primary care provider One Medical for roughly $3.9 billion in July 2022. It launched then shuttered its telehealth service, Amazon Care, along with a line of health and wellness devices.

This post appeared first on NBC NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump has 9-point lead on most important issue to voters: poll
next post
Trump foe Mitt Romney resists endorsing Harris

related articles

Prada Group says it has purchased fashion rival...

December 3, 2025

Dell family donation to offer 25 million kids...

December 3, 2025

Shopify says a daylong Cyber Monday outage has...

December 3, 2025

Starbucks to pay about $35M to NYC workers...

December 3, 2025

Apple’s AI chief abruptly steps down

December 3, 2025

Airbus says most of its recalled 6,000 A320...

December 2, 2025

Campbell’s fires executive accused of racist remarks and...

November 28, 2025

Bitcoin and other crypto assets sink in flight...

November 24, 2025

Stock market sinks as AI and interest rate...

November 24, 2025

Bargain hunters drive Walmart sales and outlook higher

November 21, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Trump appointee Barrett challenges administration on nationwide injunctions, surprises and delights liberals

    May 16, 2025
  • Republican Erik Olsen to face off against Democrat in deep blue Wisconsin district

    August 14, 2024
  • The price of Bitcoin rose to a new high this morning

    July 22, 2024
  • MAHA caucus member pledges hearings into ‘corruption’ of a public health sector ‘captured by Big Pharma’

    February 20, 2025
  • Unilever to cut 3,200 jobs in Europe by 2025 under new CEO’s growth plan

    July 12, 2024

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024

Categories

  • Economy (829)
  • Editor's Pick (7,078)
  • Investing (705)
  • Stock (963)

Latest Posts

  • Nifty retreats while German 40 rises to new all-time high

    September 5, 2024
  • Trump signs order lifting sanctions on Syria

    June 30, 2025
  • ‘Strong, conservative women’ strike back against Mark Cuban’s ‘insults’

    October 31, 2024

Recent Posts

  • ‘Red tape’: Trump admin unleashes DOGE-aligned process to fire federal workers for misconduct

    June 2, 2025
  • Trump Cabinet official vows major food stamp reforms that will help hungry children

    April 29, 2025
  • Temu retains top spot on US iOS downloads amid rising scrutiny over Chinese apps

    December 17, 2024

Editor’s Pick

  • Market crash: Nvidia stock falls amid tech pullback

    August 5, 2024
  • China’s spying in Cuba sparks alarm on Capitol Hill after fresh satellite images show surveillance buildup

    May 7, 2025
  • As Joann Fabrics and JCPenney announce store closings, here’s what’s driving the pattern

    February 17, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock